Autologous Stem Cell Transplant for Multiple Sclerosis

NCT01099930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

OTHER: immuno-ablation and autologous CD34 selected hematopoietic stem cell transplantation (HSCT),
OTHER: Standard Therapy

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]